Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD by Cahn, A., Hamblin, J.N., Begg, M., Wilson, R., Dunsire, L., Sriskantharajah, S., Montembault, M., Leemereise, C.N., Galinanes-Garcia, L., Watz, H., Kirsten, A.M., Fuhr, R., Hessel, E.M.

Get full text

Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib by Begg, M, Wilson, R, Hamblin, J N, Montembault, M, Green, J, Deans, A, Amour, A, Worsley, S, Fantom, K, Cui, Y, Dear, G, Ahmad, S, Kielkowska, A, Clark, J, Boyce, M, Cahn, A, Hessel, E M

Get full text

A competitive ELISA for the detection of group-specific antibody to equine encephalosis virus by Crafford, J.E., Guthrie, A.J., Van Vuuren, M., Mertens, P.P.C., Burroughs, J.N., Howell, P.G., Batten, C.A., Hamblin, C.

Get full text

A group-specific, indirect sandwich ELISA for the detection of equine encephalosis virus antigen by Crafford, J.E., Guthrie, A.J., van Vuuren, M., Mertens, P.P.C., Burroughs, J.N., Howell, P.G., Hamblin, C.

Get full text

Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9 by Burroughs, J.N, O'Hara, R.S, Smale, C.J, Hamblin, C, Walton, A, Armstrong, R, Mertens, P.P.C

Get full text